Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 9;40(2):269–279. doi: 10.1002/hon.2964

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 AbbVie Inc. Hematological Oncology published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

(A) Observed Response Rates and 95% Binomial CIs for Venetoclax Plus LDAC by AUC_ss Quartiles, (B) Kaplan–Meier Curves of OS and EFS by Venetoclax AUC_ss Quartiles for Venetoclax Plus LDAC, and (C) Observed Conversion to Post Baseline Transfusion Independence and 95% Binomial CIs for Venetoclax Plus LDAC by Venetoclax AUC_ss Quartiles. AUC_ss, Area under the plasma concentration‐time curve at steady state; CR, complete remission; CRi, CR with incomplete hematologic recovery; CRh, CR with partial hematologic recovery; CI, confidence intervals; EFS, event‐free survival; LDAC, low‐dose cytarabine; OS, Overall survival; RBC, red blood cell; TI, transfusion independence